Keyphrases
Liver Transplantation
100%
Acute Liver Failure
64%
Hepatitis C Virus
47%
Liver Transplant Recipients
40%
Orthotopic Liver Transplantation
38%
Hepatitis C
28%
Transplantation
28%
Chronic Hepatitis C
26%
Hepatocellular Carcinoma
26%
Interferon-α (IFN-α)
24%
Cirrhosis
22%
Liver
18%
Primary Biliary Cirrhosis
18%
Etiology
17%
Patient Survival
17%
Primary Sclerosing Cholangitis
15%
Ribavirin
15%
United States
13%
Pretransplant
13%
Cholestatic Liver Disease
13%
Acetaminophen
13%
Fibrosis
13%
Virus-specific
12%
MELD Score
12%
Allograft
11%
End-stage Liver Disease
10%
MicroRNA
10%
Graft Survival
10%
Hepatitis
9%
Liver Allograft
9%
Risk Factors
9%
Survival Rate
8%
Immunosuppression
8%
Recurrent Hepatitis
8%
Infected Patients
8%
Liver Disease
8%
Immune Response
8%
Solid Organ Transplantation
7%
Cirrhotic Liver
7%
Hepatitis C Virus Infection
7%
Clinical Outcomes
7%
Chronic Liver Disease
7%
Antiretroviral Therapy
7%
Alpha-fetoprotein
7%
Bone Disease
7%
Hepatitis B Virus
7%
Prognostic Model
7%
Autoimmune Hepatitis
7%
CD4+
7%
Hepatitis C Recurrence
7%
Medicine and Dentistry
Liver Transplantation
93%
Liver Graft
51%
Acute Liver Failure
46%
Transplantation
29%
Hepatitis C
27%
Hepatocellular Carcinoma
25%
Diseases
25%
Liver Disease
25%
Hepatitis C Virus
22%
Recurrent Disease
20%
Liver Cirrhosis
20%
Allograft
18%
Primary Biliary Cirrhosis
17%
Infection
14%
Primary Sclerosing Cholangitis
14%
Paracetamol
13%
Ribavirin
12%
End Stage Liver Disease
10%
Chronic Hepatitis C
10%
Graft Survival
9%
Neoplasm
8%
Transcatheter Arterial Chemoembolization
7%
Hepatitis B
7%
Fibrosis
7%
Virus
7%
Alpha-Fetoprotein
7%
Bone Disease
7%
Model For End Stage Liver Disease Score
7%
Peginterferon
6%
Liver Injury
6%
Immunosuppressive Treatment
6%
Cohort Analysis
6%
Biopsy Technique
6%
Bone Density
6%
Lumbar Spine
6%
Diagnosis
6%
Retransplantation
6%
Interferon
6%
Hepatitis B Virus
6%
Combination Therapy
6%
Antiviral Drug
6%
Chronic Liver Disease
6%
Liver Failure
5%
Antiviral Therapy
5%
Survival Rate
5%
Hepatitis A
5%
Model for End-Stage Liver Disease
5%
Wilson's Disease
5%
Long Term Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Liver Failure
53%
Hepatitis C
31%
Hepatitis C Virus
24%
Paracetamol
20%
Chronic Hepatitis C
17%
Infection
15%
Ribavirin
14%
Recurrent Disease
14%
Interferon
14%
Diseases
14%
Liver Disease
13%
Liver Cell Carcinoma
13%
End Stage Liver Disease
13%
microRNA
12%
Survival Rate
9%
Liver Cirrhosis
9%
Fibrosis
9%
Liver Injury
8%
Neoplasm
8%
Hepatitis B Virus
8%
Cohort Study
7%
Ethanol
6%
Primary Biliary Cirrhosis
6%
Peginterferon
6%
Hepatitis B
6%
HIV
6%
Vitamin D-Binding Protein
6%
Lamivudine
6%
Chronic Hepatitis B
6%
Isoniazid
6%
Tacrolimus
6%
Ciclosporin
6%
Ursodeoxycholic Acid
6%
Alpha Interferon
6%
Antiviral Drug
6%
Tolerability
5%
Virus Hepatitis
5%
Antiviral Therapy
5%
Hepatitis A
5%
Alpha2b Interferon
5%
Wilson's Disease
5%
Liver Failure
5%